Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Change in Receivables: 2009-2024

Historic Change in Receivables for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to -$246.7 million.

  • Fresenius Medical Care AG's Change in Receivables fell 28693.13% to -$136.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.6 million, marking a year-over-year decrease of 36733.83%. This contributed to the annual value of -$246.7 million for FY2024, which is 25739.9% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Change in Receivables stood at -$246.7 million for FY2024, which was down 25739.9% from $156.8 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Change in Receivables ranged from a high of $187.8 million in FY2021 and a low of -$246.7 million during FY2024
  • Over the past 5 years, Fresenius Medical Care AG's median Change in Receivables value was $156.8 million (recorded in 2023), while the average stood at $11.3 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Change in Receivables plummeted by 29442.12% in 2020 and then skyrocketed by 19218.03% in 2021.
  • Fresenius Medical Care AG's Change in Receivables (Annual) stood at -$203.8 million in 2020, then skyrocketed by 192.18% to $187.8 million in 2021, then decreased by 13.57% to $162.3 million in 2022, then fell by 3.44% to $156.8 million in 2023, then plummeted by 257.4% to -$246.7 million in 2024.
  • Its Change in Receivables stands at -$246.7 million for FY2024, versus $156.8 million for FY2023 and $162.3 million for FY2022.